Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes
Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes
复制标题
噻唑烷二酮类药物对人主动脉和冠状肌细胞生长和分化的影响
DOI:
10.1016/s0895-7061(97)90528-8
复制
发表时间:
1997
影响因子:
3.2
通讯作者:
H. Pershadsingh
中科院分区:
文献类型:
--
作者:
E. Morikang;S. Benson;T. Kurtz;H. Pershadsingh
Thiazolidinediones, insulin-sensitizing agents that lower insulin and lipid levels in insulin-resistant states, block agonist-induced Ca2+entry into vascular smooth muscle (VSM) cells in vitro and lower blood pressure in animals and humans in vivo. In this study, we investigated the effects of ciglitazone and troglitazone on cell growth and DNA synthesis (as thymidine incorporation), and differentiation in cultured human aorta (haVSM) and human coronary artery (hcaVSM) VSM cells. Mitotically quiescent haVSM cells were stimulated with serum or platelet-derived growth factor (PDGF). Ciglitazone (40μmol/L) inhibited haVSM cell proliferation by 84 ± 16% (mean ± SEM) (P< .05, n = 3), and serum and PDGF stimulated [3H]-thymidine incorporation by 91 ± 18% (P< .03, n = 3) and 73 ± 14% (P< .03, n = 4), respectively. Troglitazone (5μmol/L) inhibited proliferation of haVSM cells by 78 ± 14% (P< .05, n = 3) and hcaVSM cells by 91 ± 18% (P< .05, n = 3). Proliferating VSM cells (synthetic phenotype) expressed small amounts ofα-actin, whereas nonproliferating VSM cells (contractile phenotype) exhibited abundantα-actin. Exposure of proliferating haVSM cells to 40μmol/L ciglitazone induced a marked increase inα-actin staining, consistent with transition to the well differentiated, contractile phenotype. To the extent that thiazolidinediones similarly affect growth factor-induced proliferation and differentiation of arterial myocytes in vivo, these agents may be useful in treating atherosclerosis and in preventing restenosis after angioplasty. © 1997 American Journal of Hypertension, Ltd. Am J Hypertens 1997;10:428–433
登录
查看更多内容
影响因子:
2.2
作者:
KORZENIEWSKI, C;CALLEWAERT, DM
通讯作者:
CALLEWAERT, DM
影响因子:
15.9
作者:
JAWIEN, A;BOWENPOPE, DF;CLOWES, AW
通讯作者:
CLOWES, AW
影响因子:
56.9
作者:
ROSS, R;MASUDA, J;SATO, H
通讯作者:
SATO, H
DOI:
10.1161/01.hyp.24.2.170
发表时间:
1994
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Zhang,F;Sowers,JR;Ram,JL;Standley,PR;Peuler,JD
通讯作者:
Peuler,JD
影响因子:
158.5
作者:
NOLAN, JJ;LUDVIK, B;OLEFSKY, J
通讯作者:
OLEFSKY, J